1. |
|
![- - -](/image/vspace.gif) |
2. | |
![- - -](/image/vspace.gif) |
3. | |
![- - -](/image/vspace.gif) |
4. | |
![- - -](/image/vspace.gif) |
5. | |
![- - -](/image/vspace.gif) |
6. | |
![- - -](/image/vspace.gif) |
7. | |
![- - -](/image/vspace.gif) |
8. | |
![- - -](/image/vspace.gif) |
9. | |
![- - -](/image/vspace.gif) |
10. | |
![- - -](/image/vspace.gif) |
11. | |
![- - -](/image/vspace.gif) |
12. | |
![- - -](/image/vspace.gif) |
13. | |
![- - -](/image/vspace.gif) |
14. | |
![- - -](/image/vspace.gif) |
15. | |
![- - -](/image/vspace.gif) |
16. |
The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. | Leveque, C; Hoshino, T; David, P; Shoji-Kasai, Y; Leys, K; Omori, A; Lang, B; el Far, O; Sato, K; Martin-Moutot, N; | |
| |
![- - -](/image/vspace.gif) |
17. | |
![- - -](/image/vspace.gif) |
18. | |
![- - -](/image/vspace.gif) |
19. | |
![- - -](/image/vspace.gif) |
20. | |
![- - -](/image/vspace.gif) |
[ 1 2 3 4 5 8 ] Next ![Next page](/image/next.gif) |